Hepatotoxicity of botanicals

Public Health Nutrition

Volumn 3, Issue 2, 2000, Pages 113-124

  Stickel, Felix ^a   Egerer, Gerlinde ^b   Seitz, Helmut Karl ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Krankenhaus Salem   (Germany)

Author keywords

Amanita; Chaparral; Chinese medicine; Germander; Herbal hepatotoxicity; Herbal medicine; Mushroom poisoning; Pyrrolizidine alkaloids; Toxic liver injury

Indexed keywords

ANTIOXIDANT; ATRACTYLODES EXTRACT; BETAINE; CALLILEPSIS LAUREOLA EXTRACT; CHAPARRAL EXTRACT; HERBACEOUS AGENT; PENICILLIN DERIVATIVE; PLANT EXTRACT; PYRROLIZIDINE ALKALOID; S ADENOSYLMETHIONINE; SILYMARIN; THIOCTIC ACID; UNCLASSIFIED DRUG;

AMANITA PHALLOIDES; DIARRHEA; DISEASE COURSE; ECZEMA; GERMANDER; HEPATITIS C; HERBAL MEDICINE; HUMAN; INTOXICATION; LIVER DISEASE; LIVER FUNCTION; LIVER PROTECTION; LIVER TOXICITY; LIVER TRANSPLANTATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PSORIASIS; REVIEW; TOXIC HEPATITIS; TOXICITY TESTING;

EID: 0033850297     PISSN: 13689800     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1368980000000161     Document Type: Review

References (112)

1. Drugs and the liver
2. The P450 superfamily: Update on new sequences, gene mapping, and recommended nomenclature
3. Young doctor's view on alternative medicine
4. Why do people seek treatment by alternative medicine
5. Unconventional medicine in the United States. Prevalence, costs and patterns of use
6. Toxic effects of herbal tea
7. Liver injury from herbs and other botanicals
8. Herbs and hepatitis
9. Chinese herbal medicines revisited: A Hong Kong perspective
10. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis
11. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema
12. Chinese herbs for eczema
13. Toxicity of Chinese herbal remedies
14. Toxicity of traditional Chinese herbal remedies
15. Hepatitis induced by traditional Chinese herbs; possible toxic components
16. Chinese herbal medicine, fulminant hepatitis and liver transplantation
17. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan
18. Chronic hepatitis induced by Jin Bu Huan
19. Acute hepatitis associated with the use of a Chinese herbal product, Ma-Huang
20. The major scientific breakthrough of the 90's. Reducing body fat through thermogenics
21. Criteria of drug-induced liver disorders. Report of an international consensus meeting
22. The myth of beneficient nature: The risks of herbal preparations
23. Lead poisoning caused by contaminated cordyceps, a Chinese herbal preparation
24. Chinese herbs for eczema, the active compound?
25. Liver injuries induced by herbal medicine, sho-saiko-to (xiao-chai-hu-tang)
26. Prospective study of chemoprevention of hepato-cellular carcinoma with sho-saiko-to (TJ-9)
27. The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase
28. Herbal medicine sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet
29. Effects of the Japanese herbal medicine 'sho-saiko-to' (TJ-9) on in vitro interleukin-10 production by peripheral blood mononuclear cells of patients with chronic hepatitis C
30. Preliminary report of a randomized, double-blind placebo-controlled trial of a Chinese herbal medicine preparation CH-100 in the treatment of chronic hepatitis C
31. Senecio disease or cirrhosis of the liver due to senecio poisoning
32. Veno-occlusive disease of the liver with non-portal type of cirrhosis occurring in Jamaica
33. An epidemic of veno-occlusive disease of liver in central India
34. Herbal medicine and veno-occlusive disease in India
35. Azathioprine and hepatic veno-occlusive disease in renal transplant patients
36. Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in Arizona
37. Pyrrolizidine (Senecio) intoxication mimicking Reye's syndrome
38. Veno-occlusive disease and primary hepatic vein thrombosis in Israeli Arabs
39. Hepatic veno-occlusive disease due to toxic alkaloids in herbal tea
40. Venoocclusive disease of the liver secondary to ingestion of comfrey
41. Hepatic venoocclusive disease in a newborn infant of a woman drinking herbal tea
42. Drug-induced vascular and sinusoidal lesions of the liver
43. Chemical and toxin-induced liver disease
44. Hepatotoxicity of herbal remedies
45. Hepatic venocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements
46. Comfrey herb-tea-induced hepatic veno-occlusive disease
47. Plant sources of hepatotoxic pyrrolizidine alkaloids
48. The harmful potential of herbal and other plant products
49. Development of hepatic tumors in rats following ingestion of Senecio longilobus
50. Characterization of hepatic DNA damage induced in rats by the pyrrolizidine alkaloid monocrotaline
51. Plant drugs in the twenty-first century
52. Hepatite aigue a la Germandree petit-chene
53. Hepatitis after germander (Teucrium chamaedrys) administration: Another instance of herbal medicine hepatotoxicity
54. Fatal hepatitis after herbal tea
55. Hepatotoxicity of herbal remedies and mushrooms
56. Hepatite chronique active et cirrhose induites par la germandree petit-chene: A propos de trois cas
57. Hepatite chronique cirrhogene a la germandree petit-chene
58. Dihydroteugin, a neo-clerodane diterpenoid from Teucrium chamaedris
59. Neo-clerodane diterpenoids from Teucrium chamaedris: The identity of teucrin B with dihydroteugin
60. Advances in the chemistry of the furanoditerpenoids from Teucrium species
61. Metallothionine-independent hepatoprotection by zinc and sakuraso-saponin
62. Furan-induced hepatic cholangiocarcinomas in Fisher 344 rats
63. 'Intestinal-type' of adenocarcinoma preferentially induced in right/caudate liver lobes of rats treated with furan
64. Hepatic necrosis caused by furosemide
65. Bioactivation of aflatoxin B1 by human liver microsomes. Role of cytochrome P450 IIIA enzymes
66. Suicide inactivation of cytochrome p 450 by methoxalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety
67. Hepatotoxicity of germander in mice
68. Hepatotoxicity of germander (Teucrium chamedrys L.) and one of its constituent neoclerodane diterpenes, teucrin A in the mouse
69. Hepatotoxicity of the herbal medicine, germander. Metabolic activation of its furano diterpenoids by cytochrome P450 3A depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes
70. Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes
71. Liver transplantation for severe acute liver failure after herbal medicine (Teucrium polium) administration
72. Chaparral-associated hepatotoxicity
73. The use of medicinal herbs by human immunodeficiency virus-infected patients
74. Chaparral ingestion: The broadening spectrum of liver injury caused by herbal medications
75. Herbal hepatitis: Subacute hepatic necrosis secondary to chaparral leaf
76. Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism
77. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes
78. Chemical studies of phytoestrogens in flax and chaparral (43824)
79. Cholestatic hepatitis after ingestion of chaparral leaf: Confirmation by endoscopic retrograde cholangiopancreatography and liver biopsy
80. Toxicity of atractylosides in precision-cut rat and porcine renal and hepatic tissue slices
81. Herb use and necro-degenerative hepatitis
82. Hepatitis after chronic abuse of senna
83. Drug-induced liver disease: A penalty for progress
84. Mistletoe hepatitis
85. Hepatotoxicity of herbal remedies
86. The case of the salad shooters: Intravenous injection of wild lettuce extract
87. Protracted cholestatic hepatitis after the use of prostata
88. Pennyroyal toxicity: Measurement of toxic metabolite levels in two cases and review of the literature
89. The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran
90. Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: Roles of glutathione
91. Reactive intermediates in the oxidation of menthofuran by cytochromes P-450
92. Serious mushroom poisoning in California requiring hospital admission, 1990 through 1994
93. 1993 annual report of the American Association of Poison Control Centers toxic exposures surveillance system
94. Mushroom poisoning
95. Changes in liver metabolism induced by the poisons of Amanita phalloides
96. Amanita poisoning: A clinical-histopathological study of 64 cases of intoxication
97. Aucubin: Potential antidote for alpha-amanitin poisoning
98. Alpha-amanitin uptake into hepatocytes
99. Analysis of toxins of Amanita-containing mushrooms
100. Toxicokinetics of labelled amatoxins in the dog
101. A new look at an old problem: Mushroom poisoning
102. New aspects of Amanita poisoning
103. Diagnosis and treatment of Amanita-phalloides-type mushroom poisoning
104. Amanita poisoning: Treatment and the role of liver transplantation
105. Treatment of human amatoxin poisoning: Myths and advances in therapy
106. Amanita phalloides poisoning treated by early charcoal hemoperfusion
107. Curative properties against alpha-amanita poisoning by cytochrome C
108. Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides
109. Die klinische Knollenblaetterpilzvergiftung: Prognostische Faktoren und therapeutische Massnahmen
110. Treatment of alcohol-related liver disease with thioctic acid: A six months randomized double-blind trial
111. The place of liver transplantation in the treatment of acute liver failure caused by Amanita phalloides poisoning